These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8625549)

  • 1. New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy.
    Lockwood CM
    Clin Exp Immunol; 1996 May; 104 Suppl 1():77-82. PubMed ID: 8625549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin.
    Zhuang Q; Mazer B
    J Allergy Clin Immunol; 2001 Aug; 108(2):229-34. PubMed ID: 11496239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis.
    Rossi F; Jayne DR; Lockwood CM; Kazatchkine MD
    Clin Exp Immunol; 1991 Feb; 83(2):298-303. PubMed ID: 1993362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin.
    Richter C; Schnabel A; Csernok E; De Groot K; Reinhold-Keller E; Gross WL
    Clin Exp Immunol; 1995 Jul; 101(1):2-7. PubMed ID: 7621588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J; Szymanowska Z; Mazurek A
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.
    Tuso P; Moudgil A; Hay J; Goodman D; Kamil E; Koyyana R; Jordan SC
    Am J Kidney Dis; 1992 Nov; 20(5):504-8. PubMed ID: 1442764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of intravenous immunoglobulins in treating patients with vasculitis].
    Antonelli A; Agostini G; Agostini S
    Clin Ter; 1992 Sep; 141(9 Pt 2):33-6. PubMed ID: 1468195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies.
    Yuki N; Miyagi F
    J Neurol Sci; 1996 Jul; 139(1):160-2. PubMed ID: 8836989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D; Waterman SA; Gordon TP
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
    Feldmann M; Pusey CD
    J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
    Dietrich G; Kaveri SV; Kazatchkine MD
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
    Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
    Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.